01—Abstract
Summary
Summary of the 8-K filed July 14, 2025. Cited figures are marked; the original filing is the authoritative source.
Synopsys (SNPS) filed an 8-K on July 14, 2025 to furnish a press release announcing that it has received approval from all necessary authorities to proceed with its acquisition of Ansys (ANSS).
The parties expect to close the transaction on or about Thursday, July 17, 2025, subject to the satisfaction or waiver of the remaining customary closing conditions. The filing is an 'other events' disclosure (Item 8.01) and contains no financial statements, so it does not report new financial results, updated guidance, or the transaction's financial terms. The acquisition was first announced on January 16, 2024 as a combined stock and cash transaction.
Synopsys describes the strategic rationale as combining its silicon design and IP solutions with Ansys' simulation and analysis portfolio, which it says will create a leader in engineering solutions from silicon to systems for AI-powered product development. The Form S-4 registration statement was declared effective by the SEC on April 17, 2024, and the proxy statement/prospectus covers the Synopsys shares to be issued. For investors, the key development is the removal of regulatory and approval hurdles and the expected near-term closing.
The filing does not specify which authorities granted approval, the final consideration mix, the purchase price, or any post-closing financial impact, so those details should be sought in the proxy statement/prospectus and subsequent filings. The forward-looking statements caution that closing remains subject to customary conditions and to risks including legal proceedings, business disruption, and integration execution.
02—Key points
Key Highlights
- Synopsys has received approval from all necessary authorities to proceed with its acquisition of Ansys, removing a key gating item for the deal.
- The parties expect the transaction to close on or about Thursday, July 17, 2025, subject to remaining customary closing conditions.
- The Ansys acquisition was announced January 16, 2024 as a stock and cash transaction, combining Synopsys' silicon design and IP business with Ansys' simulation portfolio.
- Management positions the combination as creating the leader in engineering solutions from silicon to systems, targeting AI-powered product innovation.
- The SEC declared the Form S-4 registration statement effective on April 17, 2024, covering the Synopsys shares to be issued in the transaction.
- The filing contains no financial statements, earnings results, or guidance changes; it is a press release furnished under Item 8.01 and Exhibit 99.1.
- Closing remains subject to customary conditions, and the forward-looking statements flag risks including litigation, business disruption, and integration of Ansys' operations.
03—Questions
Frequently Asked Questions
What did Synopsys announce in this 8-K filing?
Synopsys announced in a press release (Exhibit 99.1) dated July 14, 2025 that it has received approval from all necessary authorities to proceed with its acquisition of Ansys. The filing was made under Item 8.01 (Other Events).
When is the Synopsys-Ansys deal expected to close?
The parties expect the transaction to close on or about Thursday, July 17, 2025, subject to the satisfaction or waiver of the remaining customary closing conditions.
How is the acquisition being paid for?
The filing describes the deal as a stock and cash transaction, as originally announced on January 16, 2024. It does not specify the exact mix of stock and cash, the purchase price, or the exchange ratio; those details are in the proxy statement/prospectus and the registration statement on Form S-4.
Does this filing change Synopsys' financial outlook?
No financial statements or guidance are included in this filing. It is limited to the regulatory approval announcement and the expected closing timeline, so it does not provide new financial results or projections.
What risks could still affect completion of the deal?
The forward-looking statements cite risks including failure to satisfy the remaining closing conditions, legal proceedings related to the merger agreement, business disruption after closing, and Synopsys' ability to integrate Ansys' operations and product lines. The filing refers readers to the proxy statement/prospectus and the companies' 10-K and 10-Q risk factor disclosures for more detail.
04—Continue